Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Appropriate "quality check (QC)" of mesenchymal stem cells (MSC) for regenerative therapy requires practical and quantitative marker set. Here, to establish such marker set, we investigated the profiles of gene expression in human MSCs derived from bone-marrow and synovial-tissues. By clarifying that mouse stromal progenitor cells derived from bone-marrow and synovial-tisues also showed similar differential pattern of the gene expression to that observed in human MSCs, we explored the marker set that would predict the in vitro chondrogenic potentials of the MSCs and stromal progenitor cells. Also, the potential for the unwanted ectopic calcification was evaluated by in vitro culture assays and gene expression.
|